Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors

US7838510B2 · kind B2 · utility

Assignees

• FIDIA FARMACEUTICI S.p.A. · IT
• Deutsches Krebsforschungszentrum · DE

Inventors

• Norbert Fusenig · Heidelberg, DE
• Hans Stark · Lennep, DE
• Michael Willhauck · Mannheim, DE
• Alessandra Pavesio · Padova, IT

Key dates

• Filing date: Jan 7, 2003
• Grant date: Nov 23, 2010
• Expiry date: Jan 5, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use in the medical-surgical field of biomaterials based on hyaluronic acid derivatives, optionally in association with natural, synthetic or semisynthetic biopolymers, for suppressing the angiogenic process associated with tumor proliferation (in primary and secondary tumors) is disclosed.